US Equity
AUPH
— Aurinia Pharmaceuticals Inc.Aurinia Pharmaceuticals is a biopharmaceutical company focused on developing and commercializing therapies for autoimmune diseases, including lupus nephritis.
💰 Market cap: $1.96B📍 Suite 1203-4464 Markham Street, BC, V8Z 7X8 CA🏷️ Pharmaceuticals💵 Previous close: $15.35🔢 4,976 credits left
Add Column
All
Trend
| Date ▾ | Close ▾ |
|---|---|
| 2026-07-24 | $15.35 |
| 2026-07-23 | $15.24 |
| 2026-07-22 | $15.33 |
| 2026-07-21 | $15.64 |
| 2026-07-20 | $15.25 |
| 2026-07-17 | $15.96 |
| 2026-07-16 | $15.94 |
| 2026-07-15 | $16.10 |
| 2026-07-14 | $15.98 |
| 2026-07-13 | $16.03 |
| 2026-07-10 | $15.78 |
| 2026-07-09 | $16.59 |
| 2026-07-08 | $16.23 |
| 2026-07-07 | $16.22 |
| 2026-07-06 | $15.49 |
| 2026-07-02 | $15.61 |
| 2026-07-01 | $15.80 |
| 2026-06-30 | $16.97 |
| 2026-06-29 | $16.79 |
| 2026-06-26 | $17.23 |
| 2026-06-25 | $17.55 |
| 2026-06-24 | $18.62 |
| 2026-06-23 | $17.88 |
| 2026-06-22 | $17.53 |
| 2026-06-18 | $16.46 |
| 2026-06-17 | $16.14 |
| 2026-06-16 | $16.22 |
| 2026-06-15 | $16.00 |
| 2026-06-12 | $15.82 |
| 2026-06-11 | $15.85 |
| 2026-06-10 | $15.66 |
| 2026-06-09 | $15.78 |
| 2026-06-08 | $15.66 |
| 2026-06-05 | $15.84 |
| 2026-06-04 | $16.37 |
| 2026-06-03 | $15.67 |
| 2026-06-02 | $15.39 |
| 2026-06-01 | $15.31 |
| 2026-05-29 | $15.33 |
| 2026-05-28 | $15.35 |
| 2026-05-27 | $15.54 |
| 2026-05-26 | $15.19 |
| 2026-05-22 | $15.22 |
| 2026-05-21 | $15.45 |
| 2026-05-20 | $15.90 |
| 2026-05-19 | $15.55 |
| 2026-05-18 | $15.60 |
| 2026-05-15 | $15.28 |
| 2026-05-14 | $15.84 |
| 2026-05-13 | $16.03 |
| 2026-05-12 | $15.99 |
| 2026-05-11 | $15.72 |
| 2026-05-08 | $15.23 |
| 2026-05-07 | $15.14 |
| 2026-05-06 | $16.25 |
| 2026-05-05 | $16.04 |
| 2026-05-04 | $15.77 |
| 2026-05-01 | $15.35 |
| 2026-04-30 | $15.38 |
| 2026-04-29 | $15.28 |
| 2026-04-28 | $16.04 |